Metoclopramide vs Ondansetron
Clinical Comparison
Clinical Context
Metoclopramide and ondansetron target different neurotransmitter pathways and are often used complementarily. Metoclopramide is chosen when prokinetic action is needed (gastroparesis, migraine), while ondansetron is preferred for chemotherapy-induced nausea, post-operative N&V, and when extrapyramidal risk must be avoided.
Drug Profiles
Metoclopramide
Dopamine antagonist (D2) / prokinetic anti-emetic
Mechanism
Antagonises D2 receptors in the chemoreceptor trigger zone (CTZ) and enhances gastric motility by increasing acetylcholine release from myenteric plexus and sensitising muscarinic receptors
Indications
- Nausea and vomiting (including post-operative)
- Gastroparesis
- Migraine-associated nausea (improves oral drug absorption)
- Chemotherapy-induced N&V (second-line)
Common Doses
10 mg TDS (max 30 mg/day or 0.5 mg/kg/day); max 5 days continuous use (MHRA restriction)
Route
Oral, IV, IM
Onset & Duration
IV onset: 1-3 min; Oral onset: 30-60 min; Duration: 4-6 hours
Ondansetron
5-HT3 receptor antagonist (serotonin antagonist)
Mechanism
Selectively blocks 5-HT3 serotonin receptors in the CTZ and on vagal afferents in the GI tract, preventing serotonin-mediated nausea and vomiting
Indications
- Chemotherapy-induced nausea and vomiting (first-line)
- Radiotherapy-induced nausea
- Post-operative nausea and vomiting
- Severe nausea/vomiting unresponsive to other anti-emetics
Common Doses
4-8 mg BD/TDS; IV: 4 mg slow bolus
Route
Oral (tabs, orodispersible, liquid), IV
Onset & Duration
IV onset: 5-10 min; Oral onset: 30 min; Duration: 8-12 hours
Key Differences
| Category | Metoclopramide | Ondansetron |
|---|---|---|
| Mechanism | D2 antagonist + prokinetic | 5-HT3 antagonist (serotonin blocker) |
| Prokinetic effect | Yes — speeds gastric emptying | No — may cause constipation |
| Extrapyramidal risk | Significant — dystonia, akathisia, tardive dyskinesia | None |
| Parkinson's disease | Contraindicated (worsens parkinsonism) | Safe to use |
| Chemotherapy N&V | Second-line | First-line |
| Duration restriction | MHRA: max 5 consecutive days | No specific duration limit |
| Constipation | Unlikely (prokinetic) | Common side effect |
Mechanism
D2 antagonist + prokinetic
5-HT3 antagonist (serotonin blocker)
Prokinetic effect
Yes — speeds gastric emptying
No — may cause constipation
Extrapyramidal risk
Significant — dystonia, akathisia, tardive dyskinesia
None
Parkinson's disease
Contraindicated (worsens parkinsonism)
Safe to use
Chemotherapy N&V
Second-line
First-line
Duration restriction
MHRA: max 5 consecutive days
No specific duration limit
Constipation
Unlikely (prokinetic)
Common side effect
Key Advantages
Metoclopramide
- Prokinetic effect — speeds gastric emptying (unique among anti-emetics)
- Excellent for migraine-associated nausea (enhances oral analgesic absorption)
- Cheap and widely available
- Multiple routes (oral, IV, IM)
Ondansetron
- No extrapyramidal side effects
- Safe in Parkinson's disease
- Highly effective for chemotherapy-induced N&V
- Longer duration of action than metoclopramide
- Orodispersible formulation for patients unable to swallow
Key Cautions
Metoclopramide
- MHRA: max 5 days use (risk of neurological side effects)
- Extrapyramidal side effects (acute dystonia, especially in young women)
- Tardive dyskinesia with prolonged use
- Avoid in Parkinson's disease (D2 antagonist)
- Avoid in bowel obstruction (prokinetic action)
- Avoid under age 20 except in exceptional circumstances
Ondansetron
- Constipation (common — blocks serotonin-mediated gut motility)
- QT prolongation — ECG monitoring at high doses
- Headache
- No prokinetic effect (does not improve gastric emptying)
- More expensive than metoclopramide
- Less effective for motion sickness or vestibular causes
Clinical Verdict
Use metoclopramide when prokinetic action is needed (gastroparesis, migraine) and limit to 5 days. Use ondansetron for chemotherapy/radiotherapy-induced N&V, post-operative N&V, or when extrapyramidal risk must be avoided (young women, Parkinson's disease).
Medical Disclaimer: This comparison is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare professional before making prescribing decisions. Verify all drug information with current clinical guidelines (BNF, NICE, SmPCs).
Full monographs for Metoclopramide & Ondansetron in the MedNext app
Complete dosing, interactions, contraindications, side effects, and more — covering 2,866 drugs with AI-powered search.
Download MedNext Formulary